At the signing ceremony (Photo: VNA)
HCM City (VNS/VNA) – Around 10,000 healthcare
professionals nationwide are expected to enhance their capability in diagnosing
and treating cardiovascular diseases of the elderly through a project
called “”.
The (VNHA) on April 26 signed a
memorandum of understanding (MoU) with US drug firm
Pfizer Vietnam to partner on the project “Population
Cardiovascular Health” by 2025.
The three-year project aims to improve the healthcare
professionals’ qualification in the diagnosis and treatment of cardiovascular
diseases in elderly patients through interdisciplinary coordination and the
effective use of anticoagulants.
It marks a critical milestone for a long-term collaboration
between the two parties in the advanced management of cardiovascular patients
and making a positive impact on community healthcare.
Under the MoU, the two parties will support funding to provide
updated scientific evidence and training for healthcare professionals
nationwide through activities such as online training, monthly medical
newsletters, and intensive hands-on training.
Each activity has elaborately designed content with the
participation of many leading domestic and foreign experts.
Pham Manh Hung, Vice President of the Vietnam National Heart
Association (VNHA), said the current demographic shift towards an older
population will be accompanied by a significant increase in the incidence of
cardiovascular disease in .
Cardiovascular disease is currently the most frequently diagnosed
disease, remaining the leading cause of death in the elderly.
“Therefore, it is essential for to update
their knowledge and treatment methods to optimize patient outcomes,” Hùng said.
He expects the two parties to create more effective, practical,
and sustainable activities, contributing to improving the quality of care and
serving patients.
Darrell Oh, General Director of Pfizer Vietnam, said the company
has always supported Vietnam in addressing the burden of cardiovascular
disease for many years.
Capacity-building programmes on cardiovascular disease management
as well as the appropriate use of anticoagulants in disease treatment not only
help improve the quality of health for the elderly, but also contribute to
strengthening the healthcare system in Vietnam, he said.
“This cooperation will help accelerate the ability of the
country’s healthcare system to cope with the challenges of an aging
population,” he said.
According to the United Nations Population Fund (UNFPA), Vietnam is
one of the most rapidly ageing countries in the world.
The share of the elderly population increased significantly from
8.68% in 2009 to 11.86% 2019, and is expected to reach 16.5% in 2029.
One of the major medical challenges is cardiovascular disease in
the elderly, which has already become quite common.
Cardiovascular disease in the elderly heavily affects
a patient’s quality of life, carries a high risk of mortality, and is a
significant economic burden for both individuals and society.
This disease often has comorbidities such as atrial fibrillation
with heart failure, atrial fibrillation with kidney failure, and especially
stroke./.
Source: VietnamPlus
